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Introduction. Today mental disorders are important concerns 
of health care system in all countries. Among different mental 
disorders; depression, anxiety, and somatization are more fre-
quent. This manuscript was conducted to evaluate the frequency 
of somatization symptoms, its related factors and the correlation 
between somatization symptoms and anxiety and depression dis-
orders in Iranian population. 
Methods. The cross-sectional study was conducted in Kerman, Iran, 
2017. Participants were selected from patients who referred to the 
Clinics of Educational Hospitals using convenience sampling method. 
The PHQ-15 and HADS questionnaire were used to assess the soma-
tization and depression and anxiety, respectively. The univariate and 
multivariate logistic regression was used to determine the predictive 
factors of somatization symptoms. The correlations between each 
PHQ-15 item score and anxiety and depression score were expressed.
Results. The frequency of mild, moderate and severe levels of 
somatization was 66.3%, 20.5% and 13.1%, respectively. Con-
sidering multivariate logistic regression analysis; age was asso-
ciated with somatic symptoms, significantly. The risk of somatic 
symptoms was 3.4 times more in Divorced/Widowed participants 
than single ones (p-value: 0.035). There were significant positive 
correlations between anxiety and depression scores. Each addi-
tional score of anxiety and depression were associated with 1.14 
times more likely (p-value: < 0.001) and 1.11 times less likely 
(p-value: 0.003) of having somatic symptoms, respectively.
Conclusion. The burden of somatization, depression and anxi-
ety is high in Iranian population. Psychologists and policy-
makers should consider these predictive factors for primary 
prevention of somatization at the personal and community level, 
respectively. 
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Introduction
Today mental disorders are important concerns of health 
care system in all countries, with a major burden of dis-
ease and catastrophic socio-economic effects [1]. The 
prevalence of psychological morbidity in north Amira 
and Western Europe were estimated by different stud-
ies from 14% to 50% among primary health care pa-
tients  [2,  3]. Approximately 80% of mental disorders 
occur in low or middle-income countries [1]. Among 
different mental disorders; depression, anxiety, and so-
matization are more frequent [4]. 
A population-based study on 36,000 Iranian adult popu-
lations in 2015 showed that 23.4% of them have mental 
disorders. Among cases, the prevalence of somatiza-
tion (29.8% of cases) and anxiety (29.5% of cases) was 
higher. The prevalence of mental disorder was higher 
in females, individuals living in urban areas and older 
age peoples. Single individuals, students, employed and 
more educated people suffered less frequent from men-
tal disorders comparing other groups [5]. 
Somatization is identified by multiple and recurrent 
complaints regarding somatic symptoms. Somatization 
has a chronic course and high psychiatric co-morbidity 
especially anxiety and depression. This situation causes 
the suffering of the patients and their family [6].Different 
studies concluded that 20.4% [7], or 30% [8] of patients 
with somatoform disorders suffer from anxiety and de-
pressive disorders, concurrently. Women, older people, 
and widowed or divorced individuals reported somatic 
symptoms more than others, significantly [7]. Also, the 
results of studies show somatization occurs commonly 
in people with low socio-economic status and low edu-
cational level [9].
Somatization has direct and indirect consequences on 
society. Direct consequences are resources that use to 
treat and manage it such as costs of drugs, laboratory 
tests, and health care personnel. Indirect consequences 
are absenteeism from work, reduction or loss of pro-
ductivity and quality of life. To the best of our knowl-
edge, there are limited studies about somatization and 
its risk factors among Iranian population [5, 10]. Due 
to the importance of somatization and the concurrence 
of somatization with other mental disorders, this study 
was conducted to evaluate the frequency of somatization 
symptoms, its related factors. Also, the correlation be-
tween somatization symptoms and anxiety and depres-
sion disorders was assessed in Iranian population. 
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Material and methods
This cross-sectional study was conducted in Kerman, 
Iran, from July to December 2017. Kerman Province 
covers about 3% of Iran population and is located in the 
Southeast of Iran. Participants were selected from patients 
who referred to the Clinics of Educational Hospitals. Con-
sidering Municipality district (4 districts), one Clinic of 
Educational Hospitals in each Municipality district was 
selected randomly. Individuals who have at least 18 years 
old, and did not have any dementia or mental retardation 
or medical condition requiring hospitalization were in-
cluded in the study using convenience sampling method. 
Verbal informed consent was obtained. Considering the 
prevalence of somatization symptoms in general popula-
tion as 22% [9] type I error as 0.05, confidence level as 
0.95, and precision as 0.04 the total sample size was cal-
culated as 412. Considering the design effect as 1.25, the 
total sample size was calculated as 515.
After obtaining the permission from the Ethics Committee 
of Kerman Medical University, trained interviewers de-
scribed the importance and the aim of this study and asked 
participants to complete the questionnaires carefully. The 
process of interview was continued until the completeness 
of sample size. Two questionnaires were used. The valid 
and reliable Patient Health Questionnaire-15 (PHQ-15) 
questionnaire (Cronbach’s alpha: 0.76) was used to assess 
the somatization symptoms [9]. 
Thirteen symptoms (including stomach pain, back pain, 
pain in arms, legs, and joints, headache, chest pain, dizzi-
ness, fainting spells, palpitation, shortness of breath, pain 
during sexual intercourse, Constipation/diarrhea, nausea 
and menstrual pain or problem) were asked for the last 
four weeks and participants answered them as “not both-
ered at all”, “bothered a little”, and “bothered a lot”. These 
answers were coded as a Likert scale from 0 to 2, respec-
tively. Feeling tired and Sleep problems were asked, addi-
tionally. Participants answered the questions as the Likert 
scale as 0 (“not at all”), 1 (“several days”), and 2 (“more 
than half the days” or “nearly every day”). Therefore the 
minimum and maximum score of the PHQ_15 question-
naire were 0 and 30, respectively. The total score < 5 was 
considered as no somatization disorder. Also, the total 
score classified to the three level of somatization as mild 
(Score ≥ 5), moderate (Score ≥ 10) and severe (Score 
≥  15)  [11-13]. Finally, for regression analysis, the total 
score of PHQ-15 was coded as 0 “< 10 scores” and 1 “≥ 10 
scores”. The menstruation item was excluded, because its 
function is only for women and other studies excluded 
this item from their study, therefore we can compare the 
results of this study to other studies [14].
The Hospital Anxiety and Depression Scale question-
naire (HADS) was used to assess the anxiety and de-
pression. The validity and reliability of this question-
naire were assessed later with Cronbach’s alpha 0.83 for 
anxiety subscale and 0.82 for depression subscale. This 
questionnaire measures the severity of anxiety and de-
pression through last week. This questionnaire includes 
14 items, 7 items for measuring the severity of depres-
sion and 7 items for measuring the severity of anxiety. 
The responses were coded as a Likert scale from 0 to 3. 
Therefore a total score of HADS questionnaire ranged 
from 0 to 21 for each anxiety and depression subscale. 
It is classified as normal (score: 0-7), mild (score: 8-10), 
moderate (score: 11-14), severe (score: 15-21) [15]. 
Completed questionnaires with more than 10% non-re-
sponse questions were excluded from the analysis.
HADS and PHQ are frequently used questionnaires. 
These questionnaires are self-administered, but studies 
demonstrated that these questionnaires could diagnose 
disorders with an accurate estimation [16, 17]. 
The socio-demographic questions including age, gender, 
marital status, occupational status, level of education, liv-
ing condition and socio-economic status (participants’ 
estimation of their socio-economic status) were asked at 
the end of questionnaires. The severity of somatization, 
anxiety and depression disorders were described. The 
data were analyzed using IBM SPSS 20.0 software (IBM 
SPSS Inc. Chicago, IL, USA). The univariate and multiple 
logistic regressions were used to determine the effects of 
demographic factors, and anxiety and depression score on 
somatization symptoms. After conducting univariate lo-
gistic regression analysis, all variables with P-value ≤ 0.2 
were included in the multiple logistic regression analysis 
(Enter Method).The correlation between each PHQ-15 
item score and anxiety and depression score were ex-
pressed using Pearson correlations. The significance level 
was set at 0.05(Two-tailed analysis).
Results
Sample characteristics
A total of 502 questionnaires were completed (Response 
rate: 97.5%). The socio-demographic characteristics of 
samples are described in Table I. The mean ± SD of the 
age was 44.78  ±  9.6.About 60% of participants were 
women. Majority of participants were married. Approxi-
mately 28.2% of male participants and 25.8% of female 
participants had a university education. Majority of them 
were housewife and lives in the urban area. From the 
point of view of participants, only 14% of participants 
reported their socio-economic status as bad (Tab. I). 
The mean ± SD of the total PHQ-15 score was 8.53 ± 5.6. 
The median and interquartile range was 7.9 and 7. Accord-
ing to the classification of PHQ-15 score, the frequency 
of no, mild, moderate and severe levels of somatization 
were 23.7% (n = 79), 42.6% (n = 254), 20.5% (n = 103) and 
13.2% (n = 66), respectively. Comparing different symp-
toms, feeling pain in arms, legs, and joints, stomach pain 
and headache have a highest mean score, also shortness 
of breath, chest pain, pain during sexual intercourse and 
palpitation have a lower mean score, respectively (Tab. II). 
Anxiety and depression
The mean ± SD of anxiety and depression scores were 
7.20 ± 4.9 and 5.72 ± 4.8, respectively. Nearly 56.2% of 
participants did not have any anxiety disorder and 66.2% 
of participants did not experienced depression disorders. 
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The prevalence of severe anxiety and depression were 
9.8% and 4.3%, respectively (Tab. III).
Associated factors of somatic symptoms
The results of univariate logistic regression analysis 
showed the significant association between age, mari-
tal status, education, occupational status, living condi-
tion, socio-economic status, anxiety and depression with 
somatic symptoms Results of multiple analyses showed 
that age was associated with somatic symptoms, sig-
nificantly. The 71-90 years old people were 36.10 times 
more likely to have somatic symptoms than 10-30 years 
old one (p-value: 0.004), also 51-70 years old partici-
pants were 2.81 times more likely to have these symp-









n % n % n %
Age group
10-30 years 60 30.2 100 34.2 161 32.7
31-50 years 99 49.7 141 48.3 241 48.9
51-70 years 35 17.6 44 15.1 79 16.0
71-90 years 5 2.5 7 2.4 12 2.4
Marital status
Single 49 24.3 47 15.8 96 19.2
Married 145 71.8 219 73.7 366 73.1
Divorced/Widowed 8 4.0 31 10.4 39 7.8
Education
Illiterate or primary school 19 9.4 42 14.1 61 12.2
Secondary school 27 13.4 44 14.8 71 14.1
High school 99 49.0 135 45.3 235 46.8
University 57 28.2 77 25.8 135 26.9
Occupational status
Government job 64 33.2 46 16.1 111 23.1
Non-government job 100 51.8 36 12.6 137 28.5
Retired 27 14.0 12 4.2 39 8.1
Housewife/Unemployed 2 1.0 192 67.1 194 40.3
Living Condition
Urban 173 89.2 259 91.2 434 90.4
Rural 21 10.8 25 8.8 46 9.6
Socio-economic status
Bad 30 14.9 40 13.6 70 14.1
Moderate 51 25.4 91 31.0 142 28.6
Good 62 30.8 80 27.2 142 28.6
Very good 58 28.9 83 28.2 143 28.8
PHQ-15 mean scores
Tab. II. The mean score, Standard Deviation and frequency of answers to PHQ-15 items.
Complaint Mean SD






Stomach pain 0.85 0.7 181 (36.1) 213 (42.4) 108 (21.5)
Back pain 0.60 0.6 262 (52.2) 177 (35.3) 63 (12.5)
Pain in arms, legs, joints 0.93 0.7 155 (30.9) 232 (46.2) 115 (22.9)
Headache 0.82 0.6 161 (32.1) 276 (55.0) 65 (12.9)
Chest pain 0.37 0.6 351 (69.9) 114 (22.7) 37 (7.4)
Dizziness 0.58 0.6 255 (50.8) 203 (40.4) 44 (8.8)
Fainting spells 0.68 0.6 216 (43.0) 230 (45.8) 56 (11.2)
Palpitation 0.37 0.6 362 (72.1) 94(18.7) 46 (9.2)
Shortness of breath 0.30 0.5 377 (75.1) 97 (19.3) 28 (5.6)
Pain during sexual intercourse 0.35 0.5 400 (79.7) 71 (14.1) 31 (6.2)
Constipation, diarrhea 0.55 0.6 276 (55.0) 183 (36.5) 43 (8.6)
Nausea 0.79 0.6 195 (38.8) 226 (45.0) 81(16.1)
Feeling tired 0.72 0.6 198 (39.4) 249 (49.6) 55 (11.0)
Sleep problems 0.54 0.6 290 (57.8) 154 (30.7) 58 (11.6)
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toms (p-value: 0.013). The risk of somatic symptoms 
was 3.58 times more likely in Divorced/Widowed par-
ticipants than single ones (p-value: 0.031). There were 
significant positive correlations between anxiety and 
depression scores. Each additional score of anxiety and 
depression were associated with 1.14 times more likely 
(p-value: <0.001) and 1.11 times less likely (p-value: 
0.003) of having somatic symptoms, respectively (Tab.
IV). 
The correlations between the PHQ-15 items and anxi-
ety and depression scores are described in Table V. All 
items of PHQ-15 have significant positive correlations 
with the anxiety and depression scores. Among differ-
ent items “fainting spells” was most moderately corre-
lated with anxiety score (r = 0.36) and “sleep problems” 
was most moderately associated with depression score 
(r = 0.41).
Tab. III. The measures of central tendency and dispersion of anxiety and depression score and the Frequency of severity of anxiety and depres-










Anxiety 7.20 4.9 7 7 0 21
Depression 5.72 4.8 4 8 0 21
Classification
Frequency (percent)
Normal Mild Moderate Severe
Anxiety 278 (56.2) 97 (19.6) 71 (14.1) 49 (9.8)
Depression 321 (66.2) 65 (13.4) 78 (16.1) 21 (4.3)
Tab. IV. The associated factors of somatic symptoms using univariate and multivariate logistic regression.
Variable OR 95% CI OR 95% CI
Age group
10-30 years 1.00 - 1.00 -
31-50 years 1.72 1.08-2.74 1.250 0.704-2.219
51-70 years 4.94 2.76-.87 2.817 1.240-6.401
71-90 years 18.68 3.91-89.29 36.101 3.192-408.238
Gender
Male 1.00 - 1.00 -
Female 1.03 0.70-1.49 0.88 0.45-1.76
Marital status
Single 1.00 - 1.00 -
Married 2.41 1.37-4.25 2.44 1.08-5.53
Divorced/Widowed 9.29 3.98-21.69 3.58 1.13-11.37
Education
Illiterate or primary school 6.96 3.57-13.59 1.11 0.40-3.17
Secondary school 2.83 1.51-5.28 2.08 0.88-4.92
High school 1.52 0.92-2.49 1.16 0.59-2.30
University 1.00 - 1.00 -
Occupational status
Housewife/Jobless 1.00 - 1.00 -
Government job 0.80 0.48-1.33 2.12 0.95-4.73
Non-government job 0.75 0.47-1.21 1.02 0.48-2.27
Retired 4.27 2.03-8.95 2.55 0.85-7.68
Living condition
Urban 1.00 - 1.00 -
Rural 2.55 1.38-4.71 1.30 0.58-2.93
Socio-economic status
Bad 3.53 1.92-6.49 1.178 0.487-2.850
Moderate 2.37 1.41-3.96 1.065 0.532-2.133
Good 1.31 0.76- 2.22 0.793 0.395-1.592
Very good 1.00 - 1.00 -
Anxiety 1.19 1.19-1.26 1.14 1.06-1.22
Depression 1.18 1.13-1.23 1.11 1.04-1.19
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Discussion
Physicians in primary health care settings visit many 
patients with perplexing complaints. Often these people 
had multiple visits and various treatment but they are 
unsatisfied. Somatic complaints play as the junction be-
tween physical and psychosocial aspects of illness and 
health; accordingly, physicians must be learned regard-
ing variant aspects of diseases.
In this study, the frequency of no, mild, moderate and se-
vere levels of somatization were 23.7%, 42.6%, 20.5%, 
and 13.2%, respectively. The results of a similar study in 
Germany showed that the frequency of no, mild, mod-
erate and severe levels of somatization in the general 
population in Germany was 46.8%, 38.3%, 11.8%, and 
3.1%, respectively [14]. Our study showed prevalence 
of somatic symptoms in primary care is high and about 
13.2% of patients had severe symptoms. Katon and col-
leagues introduced “The systems model of somatiza-
tion” in the patient’s socio-cultural background. These 
social and cultural factors were included in cultural at-
titudes regarding health and illness, illness behavior, and 
availability of health care facilities. Interaction between 
these factors could be affected demonstration of somati-
zation in different groups [18]. On the other hand, Pain 
experience has inter-individual variability and many fac-
tors including genetic factors, ethnicity, age, and gender 
could affect it [19].
Previous studies in Asian societies have shown that so-
matic complaints may be an appropriate way for psy-
chological distress presentation and help-seeking rather 
than direct expression [20]. Therefore it is not surpris-
ing, the prevalence of somatic complaints varies in dif-
ferent societies as 1.5 to 21.9% or even greater in the 
adult population [21]. 
In this study, most complaints were Pain in limbs, Stom-
ach pain, headache, and nausea. In some of the research-
es, the most common symptoms were a pain in limbs 
and joints, GI symptoms and headache [22, 23]. Accord-
ing to our results older age, being divorced or widow-
hood, and having anxiety or depression were associated 
with somatization symptoms. There was no difference 
regarding kinds of somatic complaints based on genders. 
Glise demonstrated the nearly equal prevalence of so-
matic complaints in men and women [21]. The results of 
a review article demonstrated that women reported more 
frequently somatic symptoms then men. In addition 
mental disorders in women were greater than men [24]. 
Biological factors, more limitations in society, gender 
social roles and traditional social stressors may play a 
role in its differences [25].
Our results showed about 43.8% and 33.8% of respon-
dents had some of degree of anxiety and depression re-
spectively. The World Health Organization (WHO) esti-
mated the lifetime prevalence of mental disorders ranged 
from 18.1 to 36.1% [26]. Based on the last Mental Health 
Survey of the Iranian Adult Population in 2015, somatic 
complaints and anxiety (29% for both) were greater than 
depression (10.39) [6]. This difference may be due to 
different setting, different questionnaire for detection 
of mental disorders and or study design [4].The preva-
lence of mental disorders was notable in this study. The 
statistical society in this study was the patients who re-
ferred to the Clinics of Educational Hospitals; therefore 
the prevalence of mental disorders was higher than the 
total population. Also, changing economic situations in 
recent years could affect Iranian mental disorders. 
WHO data demonstrated in the primary care setting 
about 70% of patients had diagnostic criteria for depres-
sion that present with somatic symptoms [27]. Since 
the psychosocial stressors could affect health, some of 
the researches were showed that anxiety and depres-
sion increase unexplained somatic complaints more than 
twice [28]. Depression and anxiety could because of so-
matic complaints. Mental disorders such as depression 
and anxiety are associated with a higher misperception 
of somatic complaints. Also, it may be the existence of 
depression or anxiety was causing more vulnerability to 
disease [22]. In other words, the somatic complaint may 
be a presentation of invisible mental disorders. Mental 
disorders were being affected by some of the variables 
such as age and marital status [5].
In present study, increasing of age was the one of impor-
tant contributing factor, in somatic complaint presenta-
tion. Impaired of function, social network changes such 
as social withdrawn are associated with poor health in old 
age persons [29]. The results of this study showed that 
the age of more than 50-year-old is a significant predic-
tor factor for somatization. The effect of age was maxi-
mized at the age of ≥ 70-year-old. The results of another 
similar study also showed the maximum score of soma-
tization was observed in ≥70-year-old participants [14]. 
In late life, some of mental health disturbances (depres-
sion, dementia) could worsen and may be affect somatic 
complaint. Patient-doctor relation, also may be affected 







r P-value r P-value
Stomach pain 0.32 < 0.001 0.30 < 0.001
Back pain 0.31 < 0.001 0.36 < 0.001
Pain in arms, legs, 
joints
0.17 < 0.001 0.13 0.006
Headache 0.25 < 0.001 0.17 < 0.001
Chest pain 0.24 < 0.001 0.34 < 0.001
Dizziness 0.31 < 0.001 0.24 < 0.001
Fainting spells 0.36 < 0.001 0.30 < 0.001
Palpitation 0.20 < 0.001 0.33 < 0.001
Shortness of breath 0.19 < 0.001 0.28 < 0.001
Pain during sexual 
intercourse
0.19 < 0.001 0.18 < 0.001
Constipation, 
diarrhea
0.20 < 0.001 0.16 < 0.001
Nausea 0.25 < 0.001 0.27 < 0.001
Feeling tired 0.25 < 0.001 0.28 < 0.001
Sleep problems 0.266 < 0.001 0.41 < 0.001
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by patient’s age. This matter may be act as contributing 
factors in attention to patients’ complaints [30].
In this study, the risk of somatic symptoms was 3.4 times 
more in Divorced/Widowed participants than single 
ones. There are different findings regarding the relation-
ship between marriage and mental disorders, but one 
Epidemiologic Catchment Area (ECA) study revealed 
married men and women had the lowest depression than 
divorced men and women [31].
Anxiety also was similar. Loss of spouse and wid-
owed has the high rate of stress and individual could 
be prone to mental disorders such as depression, Gen-
eralized Anxiety Disorders and panic disorders [32]. 
Our finding may be due to indirect effect of marital sta-
tus on depression and anxiety.
Multiple somatic complaints that associated with psy-
chiatric co morbidities are the large portion of burden 
of disease. It is expected, physician who had trained bio 
psychosocial -oriented have more appropriate approach 
to somatic complaints. Future researches regarding phy-
sicians’ diagnostic ability and their therapeutic plan are 
advised.
There were significant positive associations between 
anxiety (OR: 1.14) and depression scores (OR: 1.11) 
with somatization in this study. The results of a large 
population study in Norway showed the strong associa-
tion between anxiety, depression and somatic symptoms 
in both men and women [33]. Also, the results of a sys-
tematic review in women in low/middle income coun-
tries suggested a strong correlation between anxiety/
depression and somatization (OR ranging 2.5-3.5). This 
association has multidimensional etiology including ex-
istence the risk factors for all mental diseases or being 
anxiety/depression as a risk factor for somatization [34].
This study has a number of limitations. We used self-
report questionnaires, cross-sectional design and con-
venience sampling method. Limited sociodemographic 
data especially family and social support were other 
limitations of this study. These limitations could be a 
negative effect on the generalization of study.
Conclusion
With considering of results, having old age, being di-
vorced or widow and suffering from anxiety or depres-
sion are moderately associated with somatization. Fam-
ily physicians, psychiatrists, mental health workers and 
policy-makers should consider these predictive factors 
for primary prevention of somatization at the personal 
and community level, respectively. Physicians should 
consider the overlap syndrome between depression/anx-
iety and somatization in their primary care visits. 
Acknowledgements 
The present article is based on the thesis by Rezvan 
Aboosaeidi.
Funding sources: the present article was financially sup-
ported by Kerman University of Medical Sciences (grant 
code: 96000110).
Conflict of interest statement
The authors declare no conflict of interest.
Authors’ contributions 
BG and MD designed the study, RAboosaeidi performed 
the literature Searches and data gathering, Mina Danaei per-
formed the statistics, and BehshidGarrusi and Mina Dan-
aei wrote the manuscript. All authors commented on a first 
draft, contributed to and have approved the final manuscript.
References
[1] Jacob K, Patel V. Classification of mental disorders: a global 
mental health perspective. Lancet 2014;383:1433-5. https://doi.
org/10.1016/S0140-6736(13)62382-X
[2] Richards J, Ryan P, McCabe M, Groom G, Hickie I. Bar-
riers to the effective management of depression in general 
practice. Aust N Z J Psychiatry 2004;38:795-803. https://doi.
org/10.1080/j.1440-1614.2004.01464.x
[3] Pini S, Perkonnig A, Tansella M, Wittchen H, Psich D. Preva-
lence and 12-month outcome of threshold and subthreshold 
mental disorders in primary care. J Affect Disord 1999;56:37-8. 
https://doi.org/10.1016/s0165-0327(99)00141-x
[4] Hanel G, Henningsen P, Herzog W, Sauer N, Schaefert R, Sze-
csenyi J, Lowe B. Depression, anxiety, and somatoform disor-
ders: vague or distinct categories in primary care? Results from 
a large cross-sectional study. J Psychosom Res 2009;67:189-97.
https://doi.org/10.1016/j.jpsychores.2009.04.013
[5] Noorbala AA, Faghihzadeh S, Kamali K, Bagheri Yazdi SA, 
Hajebi A, Mousavi MT, Akhondzadeh S, Faghihzadeh E, Nouri 
B. Mental health survey of the Iranian adult population in 2015. 
Arch Iran Med (AIM) 2017;20(3). https://doi.org/0172003/
AIM.003
[6] De Waal MW, Arnold IA, Spinhoven P, Eekhof JA, van Hemert 
AM. The reporting of specific physical symptoms for mental 
distress in general practice. J Psychosom Res 2005;59:89-95. 
https://doi.org/10.1016/j.jpsychores.2005.02.011
[7] Ritsner M, Ponizovsky A, Kurs R, Modai I. Somatization in an 
immigrant population in Israel: a community survey of preva-
lence, risk factors, and help-seeking behavior. Am J Psychiatry 
2000;157:385-92. https://doi.org/10.1176/appi.ajp.157.3.385
[8] Löwe B, Spitzer RL, Williams JB, Mussell M, Schellberg D, 
Kroenke K. Depression, anxiety and somatization in primary 
care: syndrome overlap and functional impairment. Gen Hosp 
Psychiatry 2008;30:191-9. https://doi.org/10.1016/j.gen-
hosppsych.2008.01.001
[9] Abdolmohammadi K, Ghadiri Sourman Abadi F, Sadat Seyed 
Pourmand N, Falsafinejad M R. The validation of somatization 
inventory in the students of Tabriz Universities (Iran). Qom 
Univ Med Sci J 2018;11:61-7.(Persian)
[10] Heidari Z, Feizi A, Roohafza H, Keshteli AH, Adibi P. So-
matoform symptoms profiles in relation to psychological dis-
orders. A population classification analysis in a large sample 
of general adults. Psychiatry Res 2017;254:173-8. https://doi.
org/10.1016/j.psychres.2017.04.064 
[11] Van der Leeuw G, Gerrits M, Terluin B, Numans M, van der 
Feltz-Cornelis C, van der Horst H, Penninx BW, van Marwijk 
B. GARRUSI ET AL.
E406
HW. The association between somatization and disability in pri-
mary care patients. J Psychosom Res 2015;79:117-22. https://
doi.org/10.1016/j.jpsychores
[12] Shabbeh Z, Feizi A, Afshar H, Hassanzade Kashtali A, Adibi 
P. Identifying the profiles of psychosomatic disorders in an ira-
nian adult population and their relation to psychological prob-
lems. Journal of Mazandaran University of Medical Sciences. 
2016;26:82-94. (Persian)
[13] Kocalevent R-D, Hinz A, Brähler E. Standardization of a 
screening instrument (PHQ-15) for somatization syndromes in 
the general population. BMC Psychiatry 2013;13:91. https://
doi.org/10.1186/1471-244X-13-91
[14] Hinz A, Ernst J, Glaesmer H, Brähler E, Rauscher FG, Petrows-
ki K, Kocalevent RD. Frequency of somatic symptoms in the 
general population: normative values for the Patient Health 
Questionnaire-15 (PHQ-15). J Psychosom Res 2017;96:27-31. 
https://doi.org/10.1016/j.jpsychores
[15] Lukaviciute L, Navickas P, Navickas A, Grigaitiene J, Gance-
viciene R, Zouboulis C. Quality of life, anxiety prevalence, 
depression symptomatology and suicidal ideation among acne 
patients in Lithuania. J Eur Acad Dermatol Venereol 2017; 
31:1900-6. https://doi.org/10.1111/jdv.14477
[16] Djukanovic I, Carlsson J, Årestedt K. Is the Hospital Anxiety 
and Depression Scale (HADS) a valid measure in a general 
population 65-80 years old? A psychometric evaluation study. 
Health Qual Life Outcomes 2017;15:193.
[17] van Ravesteijn H, Wittkampf K, Lucassen P, van de Lisdonk E, 
van den Hoogen H, van Weert H, Huijser J, Schene A, Van Weel 
C, Speckens A. Detecting somatoform disorders in primary 
care with the PHQ-15. Ann Fam Med 2009;7:232-8. https://doi.
org/10.1370/afm.985
[18] Katon W, Ries RK, Kleinman A. The prevalence of somatiza-
tion in primary care. Compr Psychiatry 1984;25:208-15.
[19] Fillingim RB. Individual differences in pain: understanding the 
mosaic that makes pain personal. Pain 2017;158(Suppl 1):S11. 
https://doi.org/10.1097/j.pain.0000000000000775.
[20] Xiaolu Zhou A N, SeonghoMin B, JiahongSun C, SeJooKim 
D, Joung-sookAhn B, YunshiPeng E, Samuel Noh F, Ryder AG. 
Extending a structural model of somatization to South Koreans: 
Cultural values, somatization tendency, and the presentation of 
depressive symptoms. J Affect Disord 2015;176:151-4. https://
doi.org/10.1016/j.jad.2015.01.040
[21] Glise K, Ahlborg G Jr, Jonsdottir IH. Prevalence and course of 
somatic symptoms in patients with stress-related exhaustion: 
does sex or age matter. BMC Psychiatry 2014;14:118. https://
doi.org/10.1186/1471-244X-14-118
[22] Haftgoli N, Favrat B, Verdon F, Vaucher P, Bischoff T, Burnand 
B, Herzig L. Patients presenting with somatic complaints in gen-
eral practice: depression, anxiety and somatoform disorders are 
frequent and associated with psychosocial stressors. BMC Fam 
Pract 2010;11:67. https://doi.org/10.1186/1471-2296-11-67
[23] Hekmatravan R, Samsum Shariat M, Khani F, Khademi M. The 
relationship between anxiety and depression with Somatization 
in Blind people of Isfahan city. 4th International Congress on 
Psychosomatic. Azad University, Isfahan, Iran. 2012; Oct, 17-
19 (Persian).
[24] Barsky AJ, Peekna HM, Borus JF. Somatic symptom reporting 
in women and men. J Gen Intern Med 2001;16:266-75.
[25] Eagly AH. Sex differences in social behavior: a social-role in-
terpretation. Psychology Press 2013 May 13.
[26] Kessler RC, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, 
Ormel J, Üstün TB, Wang PS. The global burden of mental dis-
orders: an update from the WHO World Mental Health (WMH) 
surveys. Epidemiol Psychiatr Sci 2009;18:23-33.
[27] Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J. An 
international study of the relation between somatic symptoms 
and depression. N Engl J Med 1999;341:1329-35. https://doi.
org/10.1056/NEJM199910283411801
[28] Katon W, Sullivan M, Walker E. Medical symptoms without 
identified pathology: relationship to psychiatric disorders, 
childhood and adult trauma, and personality traits. Ann Intern 
Med 2001;134(9 Pt 2):917-25. https://doi.org/10.7326/0003-
4819-134-9_part_2-200105011-00017
[29] Hilderink PH, Collard R, Rosmalen JG, Oude Voshaar RC. 
Prevalence of somatoform disorders and medically unexplained 
symptoms in old age populations in comparison with younger 
age groups: a systematic review. Ageing Res Rev 2013; 12:151-
6. https://doi.org/10.1016/j.arr.2012.04.004
[30] Andreas S, Schulz H, Volkert J, Dehoust M, Sehner S, Suling 
A, Ausín B, Canuto A, Crawford M, Da Ronch C, Grassi L. 
Prevalence of mental disorders in elderly people: the European 
MentDis_ICF65+ study. Br J Psychiatry 2017;210:125-31. htt-
ps://doi.org/ 10.1192/bjp.bp.115.180463
[31] O’Leary CA. Infidelity and separations precipitate major de-
pressive episodes and symptoms of non-specific depression and 
anxiety. J Clin Psychol 2000;68:774-81.
[32] Keyes KM,  Pratt C, Galea S, McLaughlin KA, Koenen KC, 
Shear MK. The burden of loss: unexpected death of a loved 
one and psychiatric disorders across the life course in a na-
tional study. Am J Psychiatry 2014;171(8):864-71. https://doi.
org/10.1176/appi.ajp.2014.13081132
[33] Haug TT, Mykletun A, Dahl AA. The association between anxi-
ety, depression, and somatic symptoms in a large population: 
the HUNT-II study. Psychosom Med 2004;66:845-51. https://
doi.org/10.1097/01.psy.0000145823.85658.0c
[34] Shidhaye R, Mendenhall E, Sumathipala K, Sumathipala A, 
Patel V. Association of somatoform disorders with anxiety and 
depression in women in low and middle income countries: a 
systematic review. Int Rev Psychiatry 2013;25:65-76. https://
doi.org/10.3109/09540261.2012.748651
Received on July 15, 2018. Accepted on November 5, 2019.
Correspondence: Mina Danaei, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Imam Highway, Shahid 
Bahonar University, Afzalipour Faculty of Medicine, Community and Family Medicine Department, 7616914115 Kerman, Iran - Tel. +98 
913 3409727 - Fax +98 34 33257671 - E-mail: danaei.mina@gmail.com
How to cite this article: Garrusi B, Danaei M, Aboosaeidi R. The prevalence and predictive factors of somatization and its relationship with 
anxiety and depression in Iranian population. J Prev Med Hyg 2019;60:E400-E406. https://doi.org/10.15167/2421-4248/jpmh2019.60.4.1006
© Copyright by Pacini Editore Srl, Pisa, Italy
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others 
to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly 
cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
